Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // April 23rd, 2010 // 6:44 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that MedPanel named Frank Dolan as senior vice president and will oversee the market research firm’s commercial effectiveness solutions group. He has previously worked for Parke-Davis, Takeda Pharmaceuticals, Kos Pharmaceuticals, and, most recently, Amylin Pharmaceuticals.
Sirtris Pharmaceuticals named George Vlasuk as ceo;
SR One is now being run by Christoph Westphal;
SciQuest hired Rudy Howard as cfo;
AVI BioPharma tapped J. David Boyle II as interim ceo and president;
Qiagen hired Pia Gargiulo as sr director pharma business development;
Sangamo BioSciences named Bill Ringo as chairman;
Patheon named Mark Kontny as prez of global pharma development services;
Ampio Pharmaceuticals added Philip Coelho to its board;
Roche named Mike Burgess as head of oncology discovery and translational area;
Ladder shot thx to Robert CB on Flickr Creative Commons
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Ampio Pharmaceuticals, AVI BioPharma, MedPanel, Patheon, Qiagen, Roche, Sangamo BioSciences, SciQuest, Sirtris Pharmaceuticals, SR One